A detailed history of Mqs Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mqs Management LLC holds 3,416 shares of GILD stock, worth $227,813. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,416
Holding current value
$227,813
% of portfolio
0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$71.58 - $87.29 $244,517 - $298,182
3,416 New
3,416 $250,000
Q3 2023

Nov 13, 2023

BUY
$73.94 - $80.67 $161,558 - $176,263
2,185 Added 58.53%
5,918 $443,000
Q2 2023

Aug 10, 2023

BUY
$76.01 - $86.7 $283,745 - $323,651
3,733 New
3,733 $287,000
Q2 2022

Aug 05, 2022

SELL
$57.72 - $65.01 $303,953 - $342,342
-5,266 Reduced 56.34%
4,080 $252,000
Q1 2022

May 10, 2022

BUY
$57.92 - $72.58 $541,320 - $678,332
9,346 New
9,346 $556,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $83.6B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Mqs Management LLC Portfolio

Follow Mqs Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mqs Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mqs Management LLC with notifications on news.